NCT07104292 Pelvic Floor Muscle Training During Pregnancy
| NCT ID | NCT07104292 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern Denmark |
| Condition | Pelvic Floor |
| Study Type | INTERVENTIONAL |
| Enrollment | 734 participants |
| Start Date | 2025-10-27 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 734 participants in total. It began in 2025-10-27 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project seeks to investigate effectiveness of PFMT during pregnancy.
Eligibility Criteria
Inclusion Criteria: * Woman in the 1st trimester of pregnancy (up to 12+6 weeks of gestation) * Para 0 (no previous birth or pregnancy \> 16 weeks of gestation) * Understands, writes, and reads fluently in Danish or English * Has a smart phone or computer/tablet to reach the training program Exclusion Criteria: * Severe psychiatric illness (e.g. schizophrenia, bipolar disorder, severe depression or anxiety) * Active substance abuse * Acute social crises (e.g. homelessness, ongoing domestic violence, severe financial instability, lack of social support) * Women with limited capacity to provide informed consent (due to cognitive impairment or language barriers) * Previous pregnancy of \> 16 weeks of gestation
Contact & Investigator
Jan Stener Jørgensen
STUDY CHAIR
Esbjerg Hospital - University Hospital of Southern Denmark
Frequently Asked Questions
Who can join the NCT07104292 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pelvic Floor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07104292 currently recruiting?
Yes, NCT07104292 is actively recruiting participants. Contact the research team at greta.puriene@rsyd.dk for enrollment information.
Where is the NCT07104292 trial being conducted?
This trial is being conducted at Aabenraa, Denmark.
Who is sponsoring the NCT07104292 clinical trial?
NCT07104292 is sponsored by University of Southern Denmark. The principal investigator is Jan Stener Jørgensen at Esbjerg Hospital - University Hospital of Southern Denmark. The trial plans to enroll 734 participants.